01:53 PM EDT, 10/22/2024 (MT Newswires) -- Health care stocks fell Tuesday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.1%.

The iShares Biotechnology ETF (IBB) shed 0.2%.

In corporate news, Danaher ( DHR ) reported better-than-expected Q3 results and continues to expect full-year core revenue to decline. The shares dropped 3.3%.

Pfizer's ( PFE ) board was urged by Starboard Value Chief Executive Jeffrey Smith to hold management accountable for underperformance, Reuters reported. Pfizer ( PFE ) shares eased 0.1%.

Sangamo Therapeutics ( SGMO ) shares surged 39% after the US Food and Drug Administration has laid out a clear pathway for accelerated approval for the company's ST-920 gene therapy candidate to treat Fabry disease.